New powered brace aims to help stroke survivors walk better

NCT ID NCT04116671

Ongoing Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called the Neuromechanical Gait Assist (NMGA) that combines a powered knee brace with muscle stimulation to help people who have difficulty walking after a stroke. Five veterans with leg weakness and a stiff-legged gait will use the device in a lab while researchers fine-tune how it detects and assists their movements. The goal is to improve walking safety, speed, and energy use, but this is an early development study, not a proof of effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Neuromechanical Gait Assist (NMGA) device: a powered knee brace combined with surface muscle stimulation
What this could lead to: If successful, this could lead to a better walking aid that helps stroke survivors walk more safely and with less effort.
What could go wrong: This is a very small, early-stage study with only 5 participants, focused on device development rather than proving effectiveness. The device may not work for everyone or may need further refinement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMIPARESIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemiplegia Paresis stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMIPARESIS STROKE

Contacts and locations

Locations

Louis Stokes VA Medical Center, Cleveland, OH

Cleveland, Ohio, 44106-1702, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.